Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up. uri icon

Overview

publication date

  • April 8, 2026

Identity

Digital Object Identifier (DOI)

  • 10.1002/ajh.70275

PubMed ID

  • 41952045